Table 3.
Comparison of current study results with those of other studies involving intercalary endoprostheses
| First author, year | Number of implants | Average age (years) | Primary | Secondary | Implant | Femora | Tibiae | Humeri | Nononcologic complications | Time to complications (months) | Followup (months) | MSTS score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abudu, 1996 [1]* | 18 | 26 | 18 | – | Custom (Stanmore‡) | 13 | 3 | 2 | 9 (50%) | – | 66 | 84% |
| Aldlyami, 2005 [4] | 35 | 25 | 35 | – | Custom (Stanmore‡) | 29 | 3 | 3 | 11 (31%) | – | 107 | – |
| Ahlmann, 2006 [2] | 6 | 42 | 4 | 2 | Custom (Stryker†) | 2 | 3 | 1 | 1 (17%) | 14 | 22 | 90% |
| Damron, 2008 [9] | 32 | 65 | 3 | 29 | Stryker† lap-joint construct | – | – | 32 | 3 (14%) | 12 | 20 | 83% |
| McGrath, 2011 [24] | 13 | 35 | 11 | 2 | Custom (Stanmore‡) | – | – | 13 | 6 (46%) | 23 | 57 | 77% |
| Hanna, 2010 [18] | 23 | 41 | 22 | 1 | Custom (Stanmore‡) | 23 | – | – | 5 (22%) | 48 | 97 | 87% |
| Sewell, 2011 [33] | 18 | 42 | 17 | 1 | Custom (Stanmore‡) | – | 18 | – | 7 (39%) | 26 | 59 | 77% |
| Ruggieri, 2011 [31] | 24 | 62 | 10 | 14 | OsteoBridge§ IDSF | 11 | 5 | 8 | 8 (33%) | 16 | 29 | 86% |
| Current study, 2014 | 44 | 64 | 11 | 33 | OsteoBridge§ IDSF | 21 | 5 | 18 | 12 (27%) | 14 | 14 | 76% |